Publications by authors named "D Hagins"

Claim this Profile
S
Subcutaneous Lenacapavir in People With Multidrug-Resistant HIV-1: 156 Week Results of the CAPELLA Study.
Onyema Ogbuagu, Andrew Wiznia, Joseph P McGowan, Daniel S Berger, Catherine M Creticos, Debbie Hagins

Open Forum Infect Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final efficacy and safety of twice-yearly subcutaneous lenacapavir in treatment-naïve people with HIV: randomized study.
Debbie Hagins, Mezgebe Berhe, Gordon E Crofoot, Moti N Ramgopal, James Sims

AIDS· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of bictegravir/emtricitabine/tenofovir alafenamide in Black and Hispanic/Latine adults with HIV-1 initiating first-line therapy: 5-year follow-up from two phase III studies.
C Martorell, M Ramgopal, D Hagins, O Osiyemi, J R Arribas

HIV Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV.
Eric S Daar, Chloe Orkin, Paul E Sax, Debbie Hagins, Anton Pozniak

AIDS Res Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre-existing HIV resistance and suboptimal adherence.
Kristen Andreatta, Michelle L D'Antoni, Silvia Chang, Aiyappa Parvangada, Ross Martin, Debbie Hagins

J Med Virol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis